Comments
The board of directors of Ajanta Pharma will meet on November 3 to consider the unaudited consolidated and financial results for the quarter and half year ended September 30, 2020, and interim dividend. It will also consider a proposal for buy-back of the equity shares of the company and any other matter as the board may decide during the course of the meeting, it said in a notice to the stock exchanges. Shares of Ajanta Pharma closed 1.18 per cent at ₹1,589.55 on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.